NOR 2019
COI 1.24 %
Breed relevant health information:
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
NOR 2015
COI 0.25 %
Breed relevant health information:
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
-
2/12/2015
|
NOR 2013
COI 1.17 %
Breed relevant health information:
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
|
NOR 2010
COI 2.51 %
*
Breed relevant health information:
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
Year of death:
2014
|
|||
|
|
||
|
|||
NOR 2017
COI 0.72 %
Breed relevant health information:
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Mild / C1 / 9-12 / C / 26-35
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
-
25/3/2019
|
|
|
|
|
|||
|
SWE 2011
COI 0.94 %
Breed relevant health information:
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Fair / B1 / 4-6 / B / 11-18
Progressive retinal atrophy (prcd-PRA)
N/mut (carrier)
|
||
FIN 2008
COI 5.09 %
Breed relevant health information:
Glycogen storage disease type II (Pompe disease) (GSDII)
N/N (clear)
Hips
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA)
N/N (clear)
|
Date of birth | Year of death | Cause of death | Canine Multifocal Retinopathy 3 (CMR3) | Degenerative myelopathy (DM) | Elbows | Glycogen storage disease type II (Pompe disease) (GSDII) | Hips | Progressive retinal atrophy (prcd-PRA) | Result of general cardiovascular health checks | |
---|---|---|---|---|---|---|---|---|---|---|
Parents | ||||||||||
Lappehiets Mektige Loki
|
15 Oct 2015 | N/N (clear) | ||||||||
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Cassiopeia av Vintervidda
|
28 Feb 2017 | N/N (clear) | Mild / C1 / 9-12 / C / 26-35 | N/N (clear) | ||||||
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Hips:
Mild / C1 / 9-12 / C / 26-35
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Siblings | ||||||||||
Alnopa Kassiopeia
|
11 May 2019 | N/N (clear) | N/N (clear) | |||||||
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Alnopa Pohjantähti
|
11 May 2019 | N/N (clear) | N/N (clear) | |||||||
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Alnopa Pöytävuori
|
11 May 2019 | N/N (clear) | N/N (clear) | |||||||
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Half siblings (sire) | ||||||||||
Half siblings (dam) | ||||||||||
Alnopa Äitipuoli
|
31 Aug 2020 | N/N (clear) | Fair / B1 / 4-6 / B / 11-18 | |||||||
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Hips:
Fair / B1 / 4-6 / B / 11-18
|
||||||||||
Alnopa Haltijatar
|
31 Aug 2020 | N/N (clear) | Excellent / A1 / 0 / A / 0-4 (no >3/hip) | N/N (clear) | ||||||
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Hips:
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Alnopa Huli
|
31 Aug 2020 | N/N (clear) | Fair / B1 / 4-6 / B / 11-18 | |||||||
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Hips:
Fair / B1 / 4-6 / B / 11-18
|
||||||||||
Alnopa Suurherttua
|
31 Aug 2020 | N/N (clear) | Fair / B1 / 4-6 / B / 11-18 | |||||||
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Hips:
Fair / B1 / 4-6 / B / 11-18
|
||||||||||
Alnopa Tuhkimo
|
31 Aug 2020 | |||||||||
Alnopa Vili
|
31 Aug 2020 | N/N (clear) | Excellent / A1 / 0 / A / 0-4 (no >3/hip) | |||||||
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Hips:
Excellent / A1 / 0 / A / 0-4 (no >3/hip)
|
||||||||||
Alnopa Joukahainen
|
3 Jul 2021 | N/N (clear) | N/N (clear) | |||||||
Degenerative myelopathy (DM):
N/N (clear)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Alnopa Karhu Mesikämmen
|
3 Jul 2021 | N/N (clear) | N/N (clear) | |||||||
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Alnopa Menninkäinen
|
3 Jul 2021 | N/N (clear) | Good / A2 / 1-3 / A / 5-10 (no >6/hip) | N/N (clear) | ||||||
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Hips:
Good / A2 / 1-3 / A / 5-10 (no >6/hip)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Alnopa Päivänsäde
|
3 Jul 2021 | N/N (clear) | N/N (clear) | |||||||
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Alnopa Susi Hukka
|
3 Jul 2021 | N/N (clear) | N/N (clear) | |||||||
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Alnopa Tuonelan Joutsen
|
3 Jul 2021 | N/N (clear) | N/N (clear) | |||||||
Glycogen storage disease type II (Pompe disease) (GSDII):
N/N (clear)
Progressive retinal atrophy (prcd-PRA):
N/N (clear)
|
||||||||||
Alnopa Angerboda
|
29 Jun 2023 | |||||||||
Alnopa Aurboda
|
29 Jun 2023 | |||||||||
Alnopa Bestla
|
29 Jun 2023 | |||||||||
Alnopa Driva
|
29 Jun 2023 | |||||||||
Alnopa Yme
|
29 Jun 2023 | |||||||||
Alnopa Ametisti
|
8 Jul 2024 | |||||||||
Alnopa Helmi
|
8 Jul 2024 | |||||||||
Alnopa Keltainen
|
8 Jul 2024 | |||||||||
Alnopa Lumi Kristalli av Ailupii
|
8 Jul 2024 | |||||||||
Alnopa Savukvartsi
|
8 Jul 2024 | |||||||||
Alnopa Tulikvartsi
|
8 Jul 2024 | |||||||||
Offspring | ||||||||||
Alnopa Nyyrikki
|
23 May 2022 | |||||||||
Alnopa Pyhä Äkras
|
23 May 2022 | |||||||||
Alnopa Seppo
|
23 May 2022 | |||||||||
Alnopa Tuuri
|
23 May 2022 | |||||||||
Alnopa Ukonvasara
|
23 May 2022 |